Search filters

List of works by Zobair M Younossi

A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ-NAFLD.

scientific article published on 17 February 2017

Advances and challenges in the management of advanced fibrosis in nonalcoholic steatohepatitis

scientific article published on 15 November 2018

Among Patients With NAFLD, Treatment of Dyslipidemia Does Not Reduce Cardiovascular Mortality

scientific article published on 24 September 2018

Burden of Primary Biliary Cholangitis Among Inpatient Population in the United States

scientific article published on 28 January 2019

Changing Trends in Etiology- and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States

scientific article published on 11 February 2019

Chronic Hepatitis B Is Associated with Higher Inpatient Resource Utilization and Mortality Versus Chronic Hepatitis C.

scientific article

Chronic Kidney Disease is Independently Associated with Increased Mortality in Patients with Non-alcoholic Fatty Liver Disease

article

Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices

scientific article published on 29 June 2020

Current and Future Therapeutic Regimens for Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH).

scientific article

Cytokine balance is restored as patient-reported outcomes improve in patients recovering from chronic hepatitis C

scientific article published on 03 May 2019

Development and Validation of a Primary Sclerosing Cholangitis-Specific Patient-Reported Outcomes Instrument: The PSC PRO.

scientific article published on 20 November 2017

Development and validation of a hepatitis B-specific health-related quality of life instrument: CLDQ-HBV

scientific article published on 11 December 2020

Diagnostic Modalities for Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH) and Associated Fibrosis.

scientific article published on 9 December 2017

Direct medical costs associated with the extrahepatic manifestations of hepatitis C infection in Europe

scientific article published on 24 February 2018

Direct medical costs associated with the extrahepatic manifestations of hepatitis C virus infection in France.

scientific article published on 18 October 2017

Disparities in Liver Transplantation Resulting From Variations in Regional Donor Supply and Multiple Listing Practices

scientific article published on 5 September 2016

Disparities in mortality for chronic liver disease among Asian subpopulations in the United States from 2007 to 2016

article

Economic and Clinical Burden of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes in the U.S.

scientific article published on 28 October 2019

Editorial: a diabetologist's perspective on the diagnosis and monitoring of NAFLD-Authors' reply

scientific article published on 01 August 2020

Editorial: direct-acting antivirals significantly improve quality of life in patients with hepatitis C virus infection-Author's reply.

scientific article published in February 2018

Effectiveness of 8- or 12-weeks of ledipasvir and sofosbuvir in real-world treatment-naïve, genotype 1 hepatitis C infected patients.

scientific article published on 10 July 2017

Epidemiology of chronic liver diseases in the USA in the past three decades

scientific article published on 31 July 2019

Equitable Access to All-Oral Direct-Acting Antiviral Therapy is a Mandatory Step to Achieve Global Hepatitis C Virus Eradication.

scientific article published on 27 September 2017

Fatigue and Pruritus in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: The Impact on Patient-Reported Outcomes

scientific article published on 28 August 2020

Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

scientific article published on 01 June 2019

Hospice care in Medicare patients with primary liver cancer: the impact on resource utilisation and mortality

scientific article

Hypothetical treatment of patients with non-alcoholic steatohepatitis: Potential impact on important clinical outcomes

scientific article published on 25 November 2019

Impact of Nonmalignant Portal Vein Thrombosis in Transplant Recipients With Nonalcoholic Steatohepatitis

scientific article published on 01 January 2019

Impact of ledipasvir/sofosbuvir on the work productivity of genotype 1 chronic hepatitis C patients in Asia

scientific article

Improved Outcomes in HCV Patients Following Liver Transplantation During the Era of Direct-Acting Antiviral Agents.

scientific article published on 21 August 2017

Improvement of Hepatic Fibrosis and Patient-Reported Outcomes in Non-Alcoholic Steatohepatitis Treated with Selonsertib

scientific article published on 27 January 2018

In an era of highly effective treatment, hepatitis C screening of the United States general population should be considered

scientific article

Increased Waitlist Mortality and Lower Rate for Liver Transplantation in Hispanic Patients with Primary Biliary Cholangitis

scientific article published on 7 February 2018

Increased cancer rates in patients with chronic hepatitis C

scientific article published on 22 December 2019

Letter: the use of Fibrosis-4 score in primary care and diabetology practices-Occam's razor applied to advanced fibrosis screening. Authors' reply

scientific article published on 01 December 2020

Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis

scientific article published in 2022

Long-term trends in chronic hepatitis B virus infection associated liver transplantation outcomes in the United States

scientific article published on 8 March 2017

Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease

scientific article published on 12 August 2017

Mortality Related to Nonalcoholic Fatty Liver Disease Is Increasing in the United States

scientific article published on 14 August 2019

Mortality Risk Detected by Atherosclerotic Cardiovascular Disease Score in Patients With Nonalcoholic Fatty Liver Disease

scientific article published on 06 June 2019

Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities

scientific article published on 19 May 2020

Nonalcoholic Fatty Liver Disease and Alcoholic Liver Disease are Major Drivers of Liver Mortality in the United States

scientific article published on 04 April 2020

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation.

scientific article published on 22 December 2017

Nonalcoholic fatty liver disease: Reporting histologic findings in clinical practice

scientific article published on 27 October 2020

Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease.

scientific article

Outcomes of Liver Transplant Candidates with Primary Biliary Cholangitis: The Data from the Scientific Registry of Transplant Recipients

scientific article published on 27 August 2019

Patient-reported outcomes in patients chronic viral hepatitis without cirrhosis: The impact of hepatitis B and C viral replication

scientific article published on 02 July 2019

Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease

scientific article

Polymorphisms in the receptor for advanced glycation end-products (RAGE) gene and circulating RAGE levels as a susceptibility factor for non-alcoholic steatohepatitis (NASH).

scientific article published on 21 June 2018

Predictors of Nonalcoholic Steatohepatitis and Significant Fibrosis in Non-Obese Nonalcoholic Fatty Liver Disease

article

Prevalence, mortality and healthcare utilization among Medicare beneficiaries with Hepatitis C in Haemodialysis units

scientific article published on 02 August 2019

Quality of Life in Adolescents with Hepatitis C Treated with Sofosbuvir and Ribavirin

scientific article published on 28 November 2017

Race/ethnicity-based temporal changes in prevalence of NAFLD-related advanced fibrosis in the United States, 2005-2016

scientific article published on 29 January 2019

Real-world use of elbasvir-grazoprevir in patients with chronic hepatitis C: retrospective analyses from the TRIO network

scientific article published on 17 April 2018

Reply

Response to the letter: Hepatitis C screening in opioid epidemics in the United States and societal perspectives.

scientific article published in July 2018

Rising Rate of Liver Transplantation in the Baby Boomer Generation with Non-alcoholic Steatohepatitis in the United States

scientific article published on 3 June 2017

Securing sustainable funding for viral hepatitis elimination plans

scientific article published on 05 December 2019

Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health-related quality of life in East Asian patients with hepatitis C virus infection

scholarly article by Zobair M. Younossi published in July 2018

Sofosbuvir and velpatasvir with or without voxilaprevir in direct-acting antiviral-naïve chronic hepatitis C: patient-reported outcomes from POLARIS 2 and 3.

scientific article published on 27 November 2017

Systematic review with meta-analysis: extrahepatic manifestations in chronic hepatitis C virus-infected patients in East Asia

scientific article published on 13 February 2019

The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance from the American Association for the Study of Liver Diseases.

scientific article published on 17 July 2017

The Effect of Interferon-Free Regimens on Health-Related Quality of Life in East Asian Patients with Chronic Hepatitis C.

scientific article published on 2 December 2017

The Efficacy of New Anti-Viral Regimens for Hepatitis C Infection: Evidence from A Systematic Review

scientific article published on 10 October 2017

The Growing Burden of Disability Related to Nonalcoholic Fatty Liver Disease: Data From the Global Burden of Disease 2007-2017

scientific article published on 14 September 2020

The comprehensive outcomes of hepatitis C virus infection: A multi-faceted chronic disease

scientific article published on 01 November 2018

The epidemiology of nonalcoholic steatohepatitis

scientific article published on 20 April 2018

The impact of modifiable risk factors on the long-term outcomes of non-alcoholic fatty liver disease

scientific article published on 29 November 2019

Treatment of hepatitis C virus leads to economic gains related to reduction in cases of hepatocellular carcinoma and decompensated cirrhosis in Japan.

scientific article published on 25 February 2018

Treatment of patients waitlisted for liver transplant with all-oral direct-acting antivirals is a cost-effective treatment strategy in the United States

scientific article published on 3 March 2017

Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014

scientific article published on 04 June 2019

Underutilization of Living Donor Liver Transplantation in the United States: Bias against MELD 20 and Higher

scientific article published on 25 September 2016

Viral eradication is required for sustained improvement of patient-reported outcomes in patients with hepatitis C

scientific article published on 15 July 2018

Paulina is supported by:

About Paulina

Help